# NW Cryobank – FDA Inspection, Sep 12, 2016

Source: https://www.keypedia.com/records/fda_inspections/nw-cryobank/b77466a7-3884-46e8-b615-f6b9812b1f39
Source feed: FDA_Inspections

> FDA inspection 983345 of NW Cryobank, September 12, 2016. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 983345
- Company Name: NW Cryobank
- Inspection Date: 2016-09-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1098180 - 2019-06-27
- FDA Inspection 893021 - 2014-08-27
- [FDA Inspection 816634 - 2013-01-29](https://www.keypedia.com/records/fda_inspections/nw-cryobank/868a8640-1c83-46bf-b58b-50a6b94352d9)

Company: https://www.keypedia.com/companies/nw-cryobank/52db108f-036d-4b7f-bc58-14d7ddc1bb2f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d